Madrigal Pharmaceuticals shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Madrigal Pharmaceuticals (MDGL) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Madrigal Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Madrigal Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Madrigal Pharmaceuticals by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $11M | 24k | 458.67 |
| 2025-06-30 | $12M | 40k | 302.64 |
| 2025-03-31 | $8.7M | 26k | 331.23 |
| 2024-12-31 | $8.5M | 28k | 308.57 |
| 2024-09-30 | $4.7M | 22k | 212.22 |
| 2024-06-30 | $6.9M | 25k | 280.16 |
| 2024-03-31 | $3.8M | 14k | 267.04 |
| 2023-12-31 | $3.3M | 14k | 231.38 |
| 2023-09-30 | $2.3M | 16k | 146.04 |
| 2023-06-30 | $3.7M | 16k | 242.26 |
| 2023-03-31 | $3.7M | 16k | 242.26 |
| 2022-09-30 | $1.1M | 17k | 64.99 |
| 2022-06-30 | $1.2M | 17k | 71.58 |
| 2022-03-31 | $1.2M | 12k | 98.12 |
| 2021-12-31 | $1.1M | 12k | 84.74 |
| 2021-09-30 | $992k | 12k | 79.79 |
| 2021-06-30 | $1.2M | 12k | 97.41 |
| 2021-03-31 | $1.4M | 12k | 116.97 |
| 2020-12-31 | $1.1M | 9.4k | 118.73 |
| 2020-09-30 | $1.1M | 9.4k | 118.73 |
| 2020-06-30 | $976k | 8.6k | 113.25 |
| 2020-03-31 | $240k | 3.6k | 66.76 |
| 2019-12-31 | $641k | 7.0k | 91.11 |
| 2019-09-30 | $318k | 3.7k | 86.22 |
| 2019-06-30 | $322k | 3.1k | 104.81 |
| 2019-03-31 | $385k | 3.1k | 125.26 |
| 2018-12-31 | $316k | 2.8k | 112.72 |
| 2018-09-30 | $851k | 4.0k | 214.13 |
| 2018-06-30 | $1.3M | 4.6k | 279.69 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas